Publications by authors named "Blai Coll"

Claim this Profile
D
Diabetes associated residual atherosclerotic cardiovascular risk in statin-treated patients with prior atherosclerotic cardiovascular disease.
Yanglu Zhao, Pin Xiang, Blai Coll, J Antonio G López, Nathan D Wong

J Diabetes Complications· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-Year Residual Atherosclerotic Cardiovascular Disease Risk Prediction Model for Statin Treated Patients With Known Cardiovascular Disease.
Nathan D Wong, Yanglu Zhao, Pin Xiang, Blai Coll, J Antonio G López

Am J Cardiol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Evolocumab on the ApoA1 Remnant Ratio: A Pooled Analysis of Phase 3 Studies.
Heidi T May, Joseph B Muhlestein, Yuhui Ma, J Antonio G López, Blai Coll

Cardiol Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol-Lowering Therapy.
Dick C Chan, Gerald F Watts, Blai Coll, Scott M Wasserman, Santica M Marcovina

J Am Heart Assoc· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Statin Use Among US Adults With Chronic Kidney Disease, 1999-2014.
Matthew T Mefford, Robert S Rosenson, Luqin Deng, Rikki M Tanner, Vera Bittner, Blai Coll

J Am Heart Assoc· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolemia.
G Kees Hovingh, Frederick J Raal, Ricardo Dent, Claudia Stefanutti, Olivier Descamps, Blai Coll

J Clin Lipidol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial.
David J Webb, Blai Coll, Hiddo J L Heerspink, Dennis Andress, Yili Pritchett

Drugs R D· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy.
Michelle J Pena, Dick de Zeeuw, Dennis Andress, John J Brennan, Ricardo Correa-Rotter, Blai Coll

Diabetes Obes Metab· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of exposure response relationship of atrasentan between North American and Asian populations.
Hiddo J L Heerspink, Hirofumi Makino, Dennis Andress, John J Brennan, Ricardo Correa-Rotter, Blai Coll

Diabetes Obes Metab· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doubling of serum creatinine and the risk of cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes mellitus: a cohort study.
Cornelia Schneider, Blai Coll, Susan S Jick, Christoph R Meier

Clin Epidemiol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers.
Bauke Schievink, Dick de Zeeuw, Paul A Smink, Dennis Andress, John J Brennan, Blai Coll

Eur J Prev Cardiol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Atrasentan-Associated Fluid Retention and Change in Albuminuria in Patients with Diabetic Nephropathy.
Donald E Kohan, Hiddo J Lambers Heerspink, Blai Coll, Dennis Andress, John J Brennan

Clin J Am Soc Nephrol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease.
Jose M Valdivielso, Blai Coll, Jose L Martín-Ventura, Juan A Moreno, Jesús Egido

J Nephrol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carotid adventitial vasa vasorum and intima-media thickness in a primary prevention population.
Uchechukwu K A Sampson, Frank E Harrell, Sergio Fazio, Sam Nwosu, Nate Mercaldo, Blai Coll

Echocardiography· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy.
Dick de Zeeuw, Blai Coll, Dennis Andress, John J Brennan, Hui Tang

J Am Soc Nephrol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of carotid ultrasound in assessing carotid atherosclerosis in individuals at low-to-intermediate cardiovascular risk.
Blai Coll, Angels Betriu, Steve B Feinstein, Jose M Valdivielso, Jose L Zamorano

Rev Esp Cardiol (Engl Ed)· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose statin monotherapy versus low-dose statin/ezetimibe combination on fasting and postprandial lipids and endothelial function in obese patients with the metabolic syndrome: The PANACEA study.
Jan Westerink, John E Deanfield, Ben P Imholz, Wilko Spiering, Dick C Basart, Blai Coll

Atherosclerosis· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy of the selective endothelin A receptor antagonist, atrasentan, in patients with diabetes and chronic kidney disease (CKD).
Dennis L Andress, Blai Coll, Yili Pritchett, John Brennan, Mark Molitch

Life Sci· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between walking speed and changes in cardiovascular risk factors during a 12-day walking tour to Santiago de Compostela: a cohort study.
Remy H H Bemelmans, Paulus P Blommaert, Annemarie M J Wassink, Blai Coll, Wilko Spiering

BMJ Open· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large artery calcification on dialysis patients is located in the intima and related to atherosclerosis.
Blai Coll, Angels Betriu, Montserrat Martínez-Alonso, Maria Luisa Amoedo, Maria Vittoria Arcidiacono

Clin J Am Soc Nephrol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of carotid artery atherosclerotic lesion echogenicity and severity at standard US with intraplaque neovascularization detected at contrast-enhanced US.
Daniel Staub, Sasan Partovi, Arend F L Schinkel, Blai Coll, Heiko Uthoff

Radiology· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum levels of matrix metalloproteinase-10 are associated with the severity of atherosclerosis in patients with chronic kidney disease.
Blai Coll, Jose A Rodríguez, Lourdes Craver, Josune Orbe, Montserrat Martínez-Alonso

Kidney Int· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New advances in noninvasive imaging of the carotid artery: CIMT, contrast-enhanced ultrasound, and vasa vasorum.
Blai Coll, Vijay Nambi, Steven B Feinstein

Curr Cardiol Rep· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained activation of renal N-methyl-D-aspartate receptors decreases vitamin D synthesis: a possible role for glutamate on the onset of secondary HPT.
Eva Parisi, Milica Bozic, Mercé Ibarz, Sara Panizo, Petya Valcheva, Blai Coll

Am J Physiol Endocrinol Metab· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive imaging of the vulnerable atherosclerotic plaque.
Gerrit L ten Kate, Eric J Sijbrands, Daniel Staub, Blai Coll, Folkert J ten Cate

Curr Probl Cardiol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis